The safer management of controlled drugs
Under the Controlled Drugs (Supervision of Management and Use) Regulations 2013, the Care Quality Commission (CQC) is responsible for making sure that health and adult social care providers, and other regulators, maintain a safe environment for the management of controlled drugs in England. We do this by reporting annually to Government. This came in response to the findings of the Fourth report of the Shipman Inquiry and the Government's response to the inquiry's recommendations
In this report we make recommendations that ensure ongoing robustness of controlled drug arrangements in England. The report and its recommendations are pertinent to all controlled drugs accountable officers in England and their support teams; organisations that handle controlled drugs; healthcare professionals with a controlled drugs interest; commissioners of healthcare services and professional healthcare and regulatory bodies.
1. NHS England controlled drugs accountable officers should be aware of new models of care across their area and, where appropriate, include them in the controlled drugs local intelligence network meetings.
2. Controlled drugs accountable officers should ensure that all staff in their organisation know how to report concerns about diversion and abuse of medicines by fellow colleagues, and that these issues are handled sensitively and appropriately.
3. Prescribers must make sure that they review patients regularly, depending on their clinical need. This is to ensure that the prescribed controlled drugs and length of treatment continues to be the most appropriate for their condition and to reduce opportunities for over prescribing and diversion.
To read the full CQC report visit http://www.cqc.org.uk/sites/default/files/20170718_controlleddrugs2016_report.pdf
Conference of interest:
Controlled Drugs Summit: Safe Use, Prescribing and Management
Monday 4 December
De Vere West One Conference Centre
26 July 2017